133 related articles for article (PubMed ID: 3446223)
1. Biological effects of a proglumide derivative as cholecystokinin antagonist in conscious dogs.
Hildebrand P; Beglinger C; Köhler E; Setnikar I; Gyr K
Regul Pept; 1987 Aug; 18(3-4):213-20. PubMed ID: 3446223
[TBL] [Abstract][Full Text] [Related]
2. Effect of proglumide, a cholecystokinin receptor antagonist, on caerulein-stimulated pancreatic enzyme secretion and pancreatic polypeptide release in the dog.
Fried M; Beglinger C; Koehler E; Whitehouse I; Varga L; Gyr K
Regul Pept; 1984 Mar; 8(2):117-22. PubMed ID: 6729149
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of CR-1409, a competitive inhibitor of cholecystokinin, on pancreatic exocrine secretion in the conscious rat.
Miyasaka K; Nakamura R; Funakoshi A; Kitani K
Tohoku J Exp Med; 1988 Jun; 155(2):165-72. PubMed ID: 3212779
[TBL] [Abstract][Full Text] [Related]
4. [Inhibitory effect of CR 1409 (cholecystokinin antagonist) on pancreatic exocrine secretion in rats].
Shiratori K; Watanabe S; Shimizu K; Moriyoshi Y; Chang JH; Takeuchi T
Nihon Shokakibyo Gakkai Zasshi; 1989 Jan; 86(1):70-6. PubMed ID: 2471850
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of pentagastrin- and cholecystokinin-stimulated exocrine secretion by proglumide.
Loewe CJ; Grider JR; Gardiner J; Vlahcevic ZR
Gastroenterology; 1985 Oct; 89(4):746-51. PubMed ID: 2863192
[TBL] [Abstract][Full Text] [Related]
6. The effect of CR 1409, a potent CCK receptor antagonist, on basal and stimulated pancreatic secretion in rat.
Takács T; Nagy I; Pap A; Varró V
Pancreas; 1990; 5(1):60-4. PubMed ID: 2293712
[TBL] [Abstract][Full Text] [Related]
7. Effects of a new proglumide analogue CR 1392 on pancreatic exocrine secretion in the rat.
Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
Digestion; 1989; 42(2):61-9. PubMed ID: 2475379
[TBL] [Abstract][Full Text] [Related]
8. The anti-CCK effect of glutaramic acid derivatives in anesthetized and conscious rats.
Takács T; Nagy I; Pap A; Varró V
Pancreas; 1988; 3(4):465-70. PubMed ID: 3174609
[TBL] [Abstract][Full Text] [Related]
9. Comparison of effects of proglumide and CR 1409, a new glutaramic acid derivative, on CCK-8-induced pancreatic polypeptide and insulin secretion in the dog.
Inui A; Oya M; Inoue T; Sakatani N; Morioka H; Baba S
Horm Metab Res; 1988 Jan; 20(1):61-2. PubMed ID: 3286447
[No Abstract] [Full Text] [Related]
10. Proglumide inhibits cholecystokinin and meal-stimulated pancreatic secretion and release of pancreatic polypeptide.
Beauchamp RD; Gomez G; Nealon WH; Townsend CM; Greeley GH; Thompson JC
Surgery; 1990 Sep; 108(3):553-8. PubMed ID: 2396199
[TBL] [Abstract][Full Text] [Related]
11. Regulation of pancreatic polypeptide release is mediated through M3 muscarinic receptors.
Tanikawa M; Hayakawa T; Kondo T; Naruse S; Shibata T; Kitagawa M
Digestion; 1994; 55(6):374-9. PubMed ID: 7705550
[TBL] [Abstract][Full Text] [Related]
12. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.
Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
Dig Dis Sci; 1989 Jun; 34(6):857-64. PubMed ID: 2470557
[TBL] [Abstract][Full Text] [Related]
13. Effects of loxiglumide on pancreatic exocrine secretion stimulated by cholecystokinin-8 in conscious dogs.
Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Kasai H; Kimura K; Fujii M
Arzneimittelforschung; 1998 Jan; 48(1):52-4. PubMed ID: 9522032
[TBL] [Abstract][Full Text] [Related]
14. Proglumide analogues CR 1409 and CR 1392 inhibit cholecystokinin-stimulated insulin release more potently than exocrine secretion from the isolated perfused rat pancreas.
Okabayashi Y; Otsuki M; Nakamura T; Fujii M; Tani S; Fujisawa T; Koide M; Hasegawa H; Baba S
Pancreas; 1990 May; 5(3):291-7. PubMed ID: 2188254
[TBL] [Abstract][Full Text] [Related]
15. Role of cholecystokinin in bombesin- and meal-stimulated pancreatic polypeptide secretion in dogs.
Jansen JB; de Jong AJ; Singer MV; Niebel W; Rovati LC; Lamers CB
Dig Dis Sci; 1990 Sep; 35(9):1073-7. PubMed ID: 2390922
[TBL] [Abstract][Full Text] [Related]
16. Effects of proglumide on cholecystokinin-8-induced exocrine and endocrine pancreatic responses in conscious sheep.
Mineo H; Iwaki N; Kogishi K; Onaga T; Kato S; Zabielski R
Comp Biochem Physiol A Physiol; 1997 Nov; 118(3):759-64. PubMed ID: 9406447
[TBL] [Abstract][Full Text] [Related]
17. [The effect of cholecystokinin antagonists on satiety induced by cholecystokinin octapeptide in dogs].
Sakatani N; Inui A; Baba S
Nihon Naibunpi Gakkai Zasshi; 1989 Oct; 65(10):1149-58. PubMed ID: 2591604
[TBL] [Abstract][Full Text] [Related]
18. Cholecystokinin in the regulation of intestinal motility and pancreatic secretion in dogs.
Thor P; Laskiewicz J; Konturek P; Konturek SJ
Am J Physiol; 1988 Oct; 255(4 Pt 1):G498-504. PubMed ID: 3177646
[TBL] [Abstract][Full Text] [Related]
19. Effects of loxiglumide on pancreatic exocrine secretion stimulated by meal in conscious dogs.
Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Edano K; Kasai H; Kimura K; Fujii M
Arzneimittelforschung; 1998 Jan; 48(1):55-7. PubMed ID: 9522033
[TBL] [Abstract][Full Text] [Related]
20. Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man.
Hildebrand P; Beglinger C; Gyr K; Jansen JB; Rovati LC; Zuercher M; Lamers CB; Setnikar I; Stalder GA
J Clin Invest; 1990 Mar; 85(3):640-6. PubMed ID: 2312719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]